Profound Medical (PROF) announced superiority on the prespecified, primary safety endpoint in the Level 1 post-market CAPTAIN randomized controlled trial comparing the TULSA Procedure with robotic ...

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted ...

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

FV Hospital aims to develop into a leading robotic surgery hub in Southeast Asia, with the long-term goal of making the world ...

A landmark medical procedure in the United Kingdom has highlighted how advanced technology could transform access to ...

Hundreds of cancer patients in the region are to benefit from a new surgical robot thanks to a £1.45m donation from Sheffield Hospitals Charity, the largest ever single donation from the charity.

A surgeon in London has carried out what is being described as the United Kingdom’s first long-distance robotic operation on ...

The remarkable story of the London surgeon who has carried out the UK’s first remotely controlled prostate operation - operating on a patient 1,500 miles away in Gibraltar.

In a medical achievement that highlights how technology is reshaping modern healthcare, a surgeon in London has successfully carried out a complex cancer operation on a patient located roughly 1,500 ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for ...

Professor Prokar Dasgupta is a London-based urological surgeon who recently led a landmark medical procedure in which a ...